Combination therapies for melanoma comprising administering cobimetinib and vemurafenib

• 收藏
• 分享

专利权人:

F. HOFFMANN-LA ROCHE AG

发明人:

Chan, Iris T.,Bray, Gordon

申请号：

NZ74486213

公开号：

NZ744862A

申请日:

2013.08.15

申请国别(地区):

NZ

年份:

2019

代理人:

摘要：

The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer. Even more specifically, the invention relates to compositions comprising cobimetinib and vemurafenib and their use in the treatment of BRAF-V600 mutation-positive unresectable or metastatic melanoma.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/